StimLabs umbilical cord material for wound healing

This trial tests if adding a special placenta-based wound covering to standard care helps heal diabetic foot ulcers and venous leg ulcers faster. It's for people with wounds that haven't healed after standard treatment for at least 4 weeks.

This trial tests if a placental membrane product, when added to standard wound care, helps heal diabetic foot ulcers and venous leg ulcers faster than standard care alone.

This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.

This study compares several advanced wound treatments (called CAMPs) plus standard care to standard care alone for hard-to-heal diabetic foot ulcers and venous leg ulcers. It aims to see if the extra treatments help wounds close faster and prevent complications.

This study tests whether a special wound dressing made from human placental membrane can help heal diabetic foot ulcers or venous leg ulcers that did not close with standard care. It is for people who were in the BIOCAMP trial and whose ulcer remained open after 12 weeks of standard treatment.

This trial tests if adding an umbilical cord-based treatment to standard care helps heal diabetic foot ulcers that have not closed with usual care. It may be an option if you have a foot ulcer that is at least 4 weeks old and between 1 and 15 square centimeters in size.